AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Novel Corticotropin-releasing Hormone Analogs And Uses Thereof

Technology Benefits
This invention relates to peptide analogs of corticotropin-releasing hormone and their use for treatment of proliferative disorders of the skin and other tissues.
Technology Application
This invention relates to peptide analogs of corticotropin-releasing hormone and their use for treatment of proliferative disorders of the skin and other tissues.
Detailed Technology Description
None
Supplementary Information
Patent Number: US6849600B2
Application Number: US2002106588A
Inventor: Wei, Edward T. | Carlson, Kurt W.
Priority Date: 25 Mar 2002
Priority Number: US6849600B2
Application Date: 25 Mar 2002
Publication Date: 1 Feb 2005
IPC Current: C07K0014575 | A61K003800
US Class: 5140108 | 514012 | 5140211 | 530300 | 530317 | 530324 | 930021 | 930270 | 514002 | 514009
Assignee Applicant: The Regents of the University of California,Berkeley
Title: Corticotropin-releasing hormone analogs
Usefulness: Corticotropin-releasing hormone analogs
Summary: The peptide is useful for treating proliferative disorders (e.g. melanoma) of the skin or other tissue in human (claimed). The peptide is also useful for treating other cancers such as uterine cancer, and other diseases such as inflammatory dermatoses, psoriasis, premalignant lesions e.g. lentigo maligna, actinic keratosis, eczema, alopecia areata, hypertrichosis and keloids.
Novelty: Peptide useful for treating e.g. melanoma, psoriasis, or eczema comprises a member of the corticotropin-releasing hormone superfamily
Industry
Disease Diagnostic/Treatment
Sub Category
Cancer/Tumor
Application No.
7285534
Others

Tech ID/UC Case

17145/2002-051-0


Related Cases

2002-051-0

*Abstract

This invention relates to peptide analogs of corticotropin-releasing hormone. Particularly, the invention provides analogs wherein the 38.sup.th amino acid from the N-terminus is D-Nle, i.e. [D-Nle.sup.38 ]-CRH peptide.

*IP Issue Date
Oct 23, 2007
*Principal Investigator

Name: Kurt Carlson

Department:


Name: Edward Wei

Department:

Country/Region
USA

For more information, please click Here
Mobile Device